Related Experiment Video
Updated: Sep 27, 2025

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge
Published on: June 15, 2018
lncRNA ADAMTS9-AS1/circFN1 Competitively Binds to miR-206 to Elevate the Expression of ACTB, Thus Inducing
1Department of Ultrasound, The Fourth Affiliated Hospital of China Medical University, Shenyang 110032, China.
Insights
This study reveals a novel regulatory network involving ADAMTS9-AS1, circFN1, miR-206, and ACTB in hypertrophic cardiomyopathy (HCM). This finding offers new insights into the molecular mechanisms underlying HCM development.
Area of Science:
- Genetics
- Molecular Biology
- Cardiovascular Research
Background:
- Hypertrophic cardiomyopathy (HCM) is a genetic heart condition causing significant disability.
- Understanding the molecular pathways involved in HCM is crucial for developing effective treatments.
Purpose of the Study:
- To explore the potential roles of long noncoding RNA (lncRNA)-, circular RNA (circRNA)-, microRNA (miRNA)-, and messenger RNA (mRNA) networks in HCM.
- To identify key regulatory elements and pathways implicated in HCM pathogenesis.
Main Methods:
- Analysis of HCM-related microarray data from the GEO database to identify differentially expressed genes (DEGs).
- Utilized GeneCards and CTD databases to retrieve HCM-related target genes and STRING database for network construction.
- Predicted upstream lncRNAs, circRNAs, and miRNAs targeting ACTB using multiple bioinformatics tools.
- Validated the expression of key molecules (ADAMTS9-AS1, circFN1, miR-206, ACTB) in patient samples and used cell lines for in vitro mechanistic studies.
Main Results:
- Identified 15 candidate target genes related to HCM, with ACTB identified as a hub gene.
- Established a regulatory network: ADAMTS9-AS1 and circFN1 act as upstream regulators of miR-206, which targets ACTB.
- Observed decreased expression of ADAMTS9-AS1, circFN1, and ACTB, and increased expression of miR-206 in HCM patients.
- In vitro experiments confirmed that ADAMTS9-AS1 and circFN1 competitively bind to miR-206, upregulating ACTB expression.
Conclusions:
- The ADAMTS9-AS1/circFN1-miR-206-ACTB regulatory network is implicated in the occurrence of HCM.
- This network provides a novel theoretical basis for understanding the molecular mechanisms of HCM.
Abstract:
Hypertrophic cardiomyopathy (HCM) is a genetic cardiac disease and can result in substantial disability. The current study explored the potentials of long noncoding RNA- (lncRNA-) circular RNA- (circRNA-) microRNA- (miRNA-) messenger RNA (mRNA) networks in HCM. Firstly, HCM-related microarray data were procured from the GEO database, with differentially expressed genes (DEGs) obtained. HCM-related target genes were retrieved in combination with GeneCards and CTD databases, and candidate target genes were subsequently obtained by intersection screening. Further, an interaction network diagram of candidate target genes was constructed using the STRING database, and the hub genes in the network were determined according to the core degree. The "ClusterProfiler" package of the R software was adopted for GO and KEGG analyses of candidate target genes, to analyze the potential molecular pathways in HCM. Next, upstream miRNA, lncRNA, and circRNA of ACTB were predicted with RNAInter, mirDIP, TargetScan, DIANA-LncBase, and StarBase databases, followed by construction of lncRNA/circRNA-miRNA-mRNA coexpression networks. ACTB, miR-206, circFN1, and ADAMTS9-AS1 expression in peripheral blood samples from HCM patients and normal healthy controls were detected using RT-qPCR. Moreover, rat cardiomyocyte cell lines H9c2 and HEK293 cells were selected for in vitro verification of competitive endogenous RNA (ceRNA) regulation mechanism. A total of 15 candidate target genes related to HCM were screened using the online databases. Further protein-protein interaction analysis identified ACTB as the hub gene for HCM. The targeted binding relationship between miR-206, miR-145-5p, miR-1-3p, and ACTB was found. Furthermore, ADAMTS9-AS1 and circFN1 were discovered as the upstream genes of miR-206. Moreover, ADAMTS9-AS1, circFN1, and ACTB were found to be poorly expressed, and miR-206 was highly expressed in HCM. In vitro experimentation further confirmed that ADAMTS9-AS1 and circFN1 could competitively bind to miR-206, thereby augmenting ACTB expression. Taken all, ADAMTS9-AS1/circFN1-miR-206-ACTB regulatory network may involve in HCM occurrence, providing a novel theoretical basis for in-depth understanding of mechanism of HCM.
More Related Videos
09:16Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes
Published on: June 3, 2018
08:22Tissue-specific miRNA Expression Profiling in Mouse Heart Sections Using In Situ Hybridization
Published on: September 15, 2018
Related Concept Videos
lncRNA - Long Non-coding RNAs
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Abnormal Proliferation
Master Transcription Regulators